292 related articles for article (PubMed ID: 1680137)
1. Detection of infectious immune complexes in human immunodeficiency virus type 1 (HIV-1) infections: correlation with plasma viremia and CD4 cell counts.
Fiscus SA; Wallmark EB; Folds JD; Fryer J; van der Horst CM
J Infect Dis; 1991 Oct; 164(4):765-9. PubMed ID: 1680137
[TBL] [Abstract][Full Text] [Related]
2. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
[TBL] [Abstract][Full Text] [Related]
3. Plasma viremia in human immunodeficiency virus infection.
Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
[TBL] [Abstract][Full Text] [Related]
4. Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection.
Ohlsson-Wilhelm BM; Cory JM; Kessler HA; Eyster ME; Rapp F; Landay A
J Infect Dis; 1990 Nov; 162(5):1018-24. PubMed ID: 1977803
[TBL] [Abstract][Full Text] [Related]
5. Correlation of serum antigen and antibody concentration with clinical features in HIV infection.
Ellaurie M; Rubinstein A
Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection.
Croxson TS; Mathur-Wagh U; Handwerger S; Siroty WE; Kaminisky D; Reagan KJ; Yancovitz SR; Mildvan D
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):455-63. PubMed ID: 2111160
[TBL] [Abstract][Full Text] [Related]
7. Infectious immune complexes in HIV-1-infected patients.
Fiscus SA; Folds JD; van der Horst CM
Viral Immunol; 1993; 6(2):135-41. PubMed ID: 8216713
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantitation of human immunodeficiency virus-infected peripheral blood mononuclear cells by flow cytometry.
McSharry JJ; Costantino R; Robbiano E; Echols R; Stevens R; Lehman JM
J Clin Microbiol; 1990 Apr; 28(4):724-33. PubMed ID: 1970576
[TBL] [Abstract][Full Text] [Related]
9. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
[TBL] [Abstract][Full Text] [Related]
11. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.
Saag MS; Crain MJ; Decker WD; Campbell-Hill S; Robinson S; Brown WE; Leuther M; Whitley RJ; Hahn BH; Shaw GM
J Infect Dis; 1991 Jul; 164(1):72-80. PubMed ID: 1676046
[TBL] [Abstract][Full Text] [Related]
12. Passive immunization in ARC and AIDS.
Karpas A; Gray J; Byron N; Gilgen D; Bally V; Oates JK; Gazzard B
Biotherapy; 1990; 2(2):159-72. PubMed ID: 2144762
[No Abstract] [Full Text] [Related]
13. Relationship between cell-free viraemia, antigenaemia and antibody levels in HIV-1-infected Ethiopian patients.
Ayehunie S; Sönnerborg A; Desta B; Kefene H; Zewdie D; Britton S; Strannegård O
AIDS; 1992 Jul; 6(7):651-7. PubMed ID: 1503684
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory characteristics of HIV-1 infection in Zimbabwe.
Katzenstein DA; Latif AS; Grace SA; Basset M; Mashu A; de Villiers DM; Carrow EW; Hendry RM; Marowa E; Emmanuel JC
J Acquir Immune Defic Syndr (1988); 1990; 3(7):701-7. PubMed ID: 1972189
[TBL] [Abstract][Full Text] [Related]
16. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction.
Mermin JH; Holodniy M; Katzenstein DA; Merigan TC
J Infect Dis; 1991 Oct; 164(4):769-72. PubMed ID: 1680138
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
Berglund O; Engman K; Ehrnst A; Andersson J; Lidman K; Akerlund B; Sönnerborg A; Strannegård O
J Infect Dis; 1991 Apr; 163(4):710-5. PubMed ID: 1672701
[TBL] [Abstract][Full Text] [Related]
18. Humoral aspects of anti-HIV immune responses in Zairians with AIDS: lower antigenemia does not correlate with immune complex levels.
Kashala O; Kayembe K; Kanki P; Mukeba P; Diese M; Kalengayi M; Izzia KW; Essex M
AIDS Res Hum Retroviruses; 1993 Mar; 9(3):251-8. PubMed ID: 8471316
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evidence for human immunodeficiency virus-1 infection of liver Kupffer cells.
Housset C; Boucher O; Girard PM; Leibowitch J; Saimot AG; Bréchot C; Marche C
Hum Pathol; 1990 Apr; 21(4):404-8. PubMed ID: 2108080
[TBL] [Abstract][Full Text] [Related]
20. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
